| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥34.2B | ¥29.5B | +15.9% |
| Operating Income | ¥3.1B | ¥3.0B | +1.4% |
| Ordinary Income | ¥3.4B | ¥2.9B | +14.7% |
| Net Income | ¥1.9B | ¥2.7B | -30.5% |
| ROE | 10.2% | 17.1% | - |
FY2025 consolidated results show revenue of 34.2B yen (YoY +15.9%) with operating income of 3.1B yen (+1.4%), marking continued top-line growth but limited margin expansion. Ordinary income reached 3.4B yen (+14.7%) while net income declined to 1.9B yen (-30.5%), primarily due to elevated tax burden with an effective tax rate of 36.0%. The revenue growth represents the continuation of expansion momentum, though profitability improvements remain constrained. Operating cash flow of 2.1B yen (-43.9% YoY) generated free cash flow of 1.4B yen, maintaining positive cash generation despite year-over-year decline.
Revenue increased 4.7B yen to 34.2B yen, driven by geographic expansion with domestic sales growing to 29.4B yen and Vietnam operations contributing 3.5B yen. The company operates primarily in consulting services as a single reportable segment, with investment operations representing non-material contributions. Geographic diversification progressed with overseas revenue (Vietnam and other regions) reaching approximately 4.8B yen, demonstrating successful regional expansion beyond the domestic market. Gross profit margin remained stable at 44.4% with cost of sales of 19.0B yen, while SG&A expenses of 12.1B yen represented 35.4% of revenue. Operating income growth of 1.4% significantly lagged revenue growth, indicating operating leverage limitations and suggesting that cost structure scaled proportionally with revenue expansion. The gap between operating income (3.1B yen) and ordinary income (3.4B yen) reflects positive non-operating contributions of approximately 0.3B yen, primarily from partnership gains of 0.4B yen and interest income of 0.1B yen. The substantial divergence between ordinary income (3.4B yen) and net income (1.9B yen) stems from high tax burden of 1.3B yen (effective tax rate 36.0%) and net extraordinary items. Extraordinary income of 0.3B yen included gains on sale of securities (1.1B yen), partially offset by valuation losses (0.1B yen). The tax burden coefficient of 0.615 indicates that taxes consumed approximately 38.5% of pre-tax profit, significantly compressing bottom-line results. Non-controlling interests absorbed 0.1B yen of income, further reducing parent company net income. This represents a revenue growth/profit decline pattern, where top-line expansion did not translate to proportional bottom-line improvement due to tax structure and cost dynamics.
The company operates consulting services as a single reportable segment with investment operations representing quantitatively immaterial contributions. Within the consulting business, key clients include pharmaceutical distribution companies, with Ampharma Co., Ltd. generating 4.9B yen in revenue and Tsuruha Holdings contributing 3.9B yen, collectively representing approximately 25.7% of total revenue. The consulting segment serves as the core business driving substantially all revenue and operating profit. Geographic breakdown shows domestic operations (29.4B yen, 86.0% of revenue) as the primary profit center, with Vietnam operations (3.5B yen, 10.1%) and other regions (1.3B yen, 3.9%) representing growth markets. Margin differences between geographic segments are not disclosed, though the overseas expansion supports revenue diversification while the domestic market remains the earnings foundation.
[Profitability] ROE of 10.2% reflects moderate return on equity with operating margin at 9.0% (down from 10.0% prior year), indicating slight margin compression despite revenue growth. Gross profit margin of 44.4% remained stable while net profit margin declined to 5.4% from 9.1% prior year, primarily attributable to elevated tax burden. [Cash Quality] Cash and deposits of 13.8B yen provide substantial liquidity, covering short-term liabilities 2.3 times and representing 51.4% of total assets. Operating cash flow of 2.1B yen represents 0.97 times net income, confirming reasonable cash-backed earnings quality. [Investment Efficiency] Total asset turnover of 1.27 reflects efficient asset utilization. Property, plant and equipment of 1.6B yen and intangible assets of 1.0B yen (surged from 0.07B yen prior year) indicate recent investment activity, likely M&A-related. Goodwill of 0.5B yen requires monitoring for potential impairment. [Financial Health] Equity ratio of 67.9% demonstrates strong capital adequacy with total equity of 18.2B yen. Current ratio of 337.5% indicates robust short-term solvency. Long-term loans increased substantially to 2.7B yen from 0.5B yen prior year, though debt-to-equity ratio remains conservative at 0.15. Interest coverage is exceptionally strong with minimal interest expense of 0.03B yen.
Operating cash flow of 2.1B yen represents 0.97 times net income, confirming cash-backed earnings though showing decline from prior year's 3.7B yen. Cash flow subtotal before working capital changes stood at 4.1B yen, with significant cash outflow from income taxes paid of 2.0B yen reflecting the elevated tax burden observed in P&L. Working capital movements included receivables increase of 0.5B yen corresponding to revenue growth, while contract liabilities increased 0.3B yen indicating advance customer payments. Investing cash flow of negative 0.7B yen comprised capital expenditure of 0.1B yen, suggesting limited tangible asset investment with the balance likely representing intangible asset or M&A-related investments given the 13-fold increase in intangible fixed assets on balance sheet. Financing cash flow of negative 0.2B yen reflected share repurchases of 0.4B yen, partially offset by long-term borrowing inflows. Free cash flow of 1.4B yen (operating CF plus investing CF) demonstrates continued cash generation capability, though the FCF coverage of dividends stands at 0.98 times, indicating nearly full utilization of free cash for shareholder returns.
Ordinary income of 3.4B yen versus operating income of 3.1B yen shows non-operating net contribution of approximately 0.3B yen, representing 0.9% of revenue. Non-operating income of 0.5B yen comprised primarily partnership gains of 0.4B yen and interest income of 0.1B yen, with negligible foreign exchange gains. These items appear largely recurring in nature given the partnership structure, though specific sustainability requires continued monitoring. Non-operating expenses of 0.2B yen remained minimal with interest expense of only 0.03B yen despite increased long-term debt, reflecting favorable borrowing terms. Extraordinary items totaling net 0.2B yen included gains on sale of securities of 1.1B yen offset by valuation losses of 0.1B yen, representing non-recurring factors that should be excluded from normalized earnings assessment. The significant gap between pre-tax profit of 3.5B yen and net income of 1.9B yen stems from tax expense of 1.3B yen (36.0% effective rate), suggesting limited tax efficiency compared to standard corporate rates. Operating cash flow of 2.1B yen slightly below net income of 1.9B yen (ratio 0.97) indicates reasonable earnings quality, though the cash conversion rate of 0.64 (OCF/EBITDA) suggests room for improvement in converting EBITDA to actual cash. The combination of stable gross margins, reasonable OCF/net income ratio, but elevated tax burden indicates core operations generate quality earnings, though cash conversion efficiency and tax optimization warrant attention.
Full-year guidance projects revenue of 39.4B yen (YoY +15.1%), operating income of 4.0B yen (+30.6%), and ordinary income of 3.8B yen (+11.7%). Current progress rates through this fiscal year show revenue achievement at 86.8%, operating income at 76.5%, and ordinary income at 88.4% against full-year targets. Operating income progress of 76.5% trails the revenue progress of 86.8%, suggesting management expects significant second-half margin improvement to achieve the +30.6% operating income growth target. The projected operating income of 4.0B yen implies operating margin expansion to approximately 10.2% from current 9.0%, requiring either revenue scale benefits or cost optimization in remaining periods. The guidance indicates management confidence in profitability recovery following the current period's margin compression. No explicit assumptions regarding contract backlog or pipeline visibility are disclosed, though the consulting business model with key client relationships (Ampharma and Tsuruha Holdings representing significant revenue) provides some revenue predictability. The forecast notes acknowledge that projections are based on currently available information and reasonable assumptions, with actual results subject to variance from multiple factors.
Annual dividend of 45 yen per share (paid as year-end dividend, with no interim dividend) represents total dividend distribution. The payout ratio relative to basic EPS of 71.78 yen stands at 62.7%, while the company reports a payout ratio of 44.9% suggesting different calculation methodology. Dividend per share increased from prior levels, maintaining shareholder return commitment despite net income decline. Share repurchases of 0.4B yen were executed during the period, demonstrating additional capital return beyond dividends. Total shareholder returns combining dividends and buybacks relative to free cash flow of 1.4B yen indicate comprehensive capital allocation to shareholders. The combined return approach reflects management's balanced capital deployment strategy between business investment and shareholder value return, though the high utilization rate of free cash flow for returns leaves limited buffer for unexpected investment needs or market changes.
Customer concentration risk represents the primary business risk, with top two clients (Ampharma 4.9B yen and Tsuruha Holdings 3.9B yen) accounting for approximately 25.7% of total revenue. Loss of or significant reduction in business from either major client would materially impact financial results. Single segment concentration in consulting services creates vulnerability to sector-specific demand fluctuations, with limited business diversification to offset consulting market dynamics. The intangible asset increase to 1.0B yen (from 0.07B yen prior year) and goodwill of 0.5B yen introduce impairment risk if acquired business or assets fail to generate projected returns, requiring close monitoring of asset carrying values against future cash generation.
[Industry Position] (Reference - Proprietary Analysis) The company demonstrates solid revenue growth momentum of 15.9% compared to general consulting industry growth trends, positioning favorably for market share expansion. Operating margin of 9.0% reflects moderate profitability in the consulting services sector, where margins typically range from 8-15% depending on service mix and scale. The equity ratio of 67.9% exceeds typical industry medians of 50-60%, indicating conservative financial management with lower leverage utilization than peers. ROE of 10.2% aligns with mid-tier consulting firms, though trailing higher-performing peers achieving 15%+ returns through greater operating leverage or capital efficiency. Cash conversion characteristics show room for improvement versus industry best practices, where leading firms maintain OCF/EBITDA ratios exceeding 0.8. The geographic expansion into Vietnam and overseas markets follows industry trends of regional diversification, though domestic market dependency at 86% of revenue remains higher than multinational consulting competitors. Client concentration with top customers representing 25.7% of revenue exceeds typical diversification standards in the consulting sector, where firms target maximum 10-15% exposure to single clients for risk management. (Industry: Professional Services/Consulting Sector, Comparison: Prior fiscal period and sector medians, Source: Proprietary analysis)
The financial results reveal a company in transition, balancing aggressive revenue growth (15.9%) against profitability headwinds from elevated tax burden and cost structure scaling. The substantial increase in intangible assets (13-fold) and long-term debt (5-fold) indicates strategic investment activity, likely M&A or business expansion, creating future earnings potential contingent on successful integration and return generation. Cash flow characteristics show adequate liquidity and positive generation (FCF 1.4B yen) supporting both shareholder returns and operations, though the near-full utilization of free cash flow for dividends and buybacks leaves limited cushion for unexpected needs. The consulting business model with key client relationships provides revenue stability, though concentration risk to top two clients warrants monitoring for contract renewals and relationship sustainability. Management guidance projecting significant operating income improvement (+30.6%) versus modest revenue growth (+15.1%) implies confidence in margin recovery, requiring execution on cost leverage and successful realization of recent investments. The elevated tax burden (36% effective rate) represents a structural profitability constraint unless addressed through tax optimization or jurisdictional mix changes.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.